Investigation into the accumulation of amyloid as a biomarker for cancer

Principal Investigator: Dr Susana Ros, CRUK Cambridge Institute

Co-Investigator:
 Professor David Klenerman, Department of Physical Chemistry

Funded by: CRUK Cambridge Centre Early Detection Programme Pump Priming Awards 2016

Amyloid has long been known to accumulate in neurodegenerative disease. Recent work has demonstrated that amyloid also accumulates in cancer. The amyloid formed offers potentially an entirely new way to detect cancer. Our long-term vision is to study whether measurements of amyloid can be used as a method for early disease detection.